Broad Institute

Pharmalot By Ed Silverman

European regulator suspends generic drugs after finding flawed studies

Health By Andrew Joseph

U.S. reports 180 cases of unexplained hepatitis in children, as researchers investigate potential causes

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Biotech By Jonathan Wosen

‘No real clear path’: Insurance coverage for cutting-edge diagnostics remains a major challenge for personalized medicine

Pharmalot By Ed Silverman

Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others

First Opinion By Michael L. Millenson and J. Matthew Austin

To improve safety, hospitals should make ‘radical transparency’ real — and accessible

First Opinion By Steven C. Schlozman

Hopelessness around youth mental health is creating a ‘nihilistic contagion’

Health By Olivia Goldhill

Vague ‘medical emergency’ exceptions in abortion laws leave pregnant people in danger, doctors say